SEC 13F Intelligence

Lion Point Capital, LP / MIST

Lion Point Capital, LP’s Milestone Pharmaceuticals In Position

Does Lion Point Capital, LP own Milestone Pharmaceuticals In (MIST)? Yes — 820.0K shares worth $975,800 (+5.83% of its 13F portfolio) as of Q1 2026, up from 755.0K shares the prior filed quarter.

Position Value
$975,800
Q1 2026
Shares
820.0K
% of Portfolio
+5.83%
Quarters Held
17
currently held

Position History MIST

Reported value by quarter
Q1 ’22: $4MQ1 ’22Q2 ’22: $6MQ3 ’22: $11MQ4 ’22: $3MQ4 ’22Q1 ’23: $2MQ2 ’23: $1MQ3 ’23: $1MQ3 ’23Q4 ’23: $3MQ1 ’24: $4MQ2 ’24: $3MQ2 ’24Q3 ’24: $3MQ4 ’24: $2MQ1 ’25: $439,100Q1 ’25Q2 ’25: $1MQ3 ’25: $1MQ4 ’25: $2MQ4 ’25Q1 ’26: $975,800filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026820.0K$975,800+5.83%
Q4 2025755.0K$2M+7.89%
Q3 2025658.6K$1M+7.48%
Q2 2025548.8K$1M+7.23%
Q1 2025548.8K$439,100+2.80%
Q4 20241.03M$2M+12.68%
Q3 20241.65M$3M+5.60%
Q2 20242.34M$3M+5.63%
Q1 20242.30M$4M+2.30%
Q4 20231.65M$3M+1.38%
Q3 2023450.2K$1M+0.62%
Q2 2023450.2K$1M+0.58%
Q1 2023425.2K$2M+0.69%
Q4 2022425.2K$3M+0.41%
Q3 20221.56M$11M+2.46%
Q2 2022948.6K$6M+0.64%
Q1 2022683.6K$4M+1.02%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Lion Point Capital, LP’s full portfolio or all institutional holders of MIST.